CD8 cytotoxic T cells in cutaneous leishmaniasis

Parasite Immunology

Volumn 29, Issue 12, 2007, Pages 671-678

  Ruiz, J H ^a   Becker, I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

CD8 T cell; Cytotoxicity; Leishmana

Indexed keywords

CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON;

APOPTOSIS; CD8+ T LYMPHOCYTE; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DISEASE MODEL; HOST RESISTANCE; HUMAN; INFECTION CONTROL; LEISHMANIA; MACROPHAGE; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LEISHMANIASIS, CUTANEOUS; T-LYMPHOCYTES, CYTOTOXIC;

MURINAE;

EID: 36549027818     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.00991.x     Document Type: Review

References (66)

1. Handman E. Cell biology of Leishmania. Adv Parasitol 1999 44 : 1 39.
2. Courret N, Frehel C, Gouhier N, et al. Biogenesis of Leishmania- harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. J Cell Sci 2002 115 : 2303 2316.
3. Roberts LJ, Handman E Foote SJ. Science, medicine, and the future: leishmaniasis. BMJ 2000 321 : 801 804.
4. Berman J. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997 24 : 684 703.
5. + cells from lesions of patients with localized cutaneous leishmaniasis. Braz J Med Biol Res 2000 33 : 317 325.
6. Hailu A Frommel D. Leishmaniasis. In Kloos H, Ahmed Z (eds) : The Ecology of Health and Disease in Ethiopia. Oxford, Westview Press, 1993 : 375 388.
7. Becker I, Salaiza N, Aguirre M, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll like receptor-2. Mol Biochem Parasitol 2003 130 : 65 74.
8. Carrada G, Cañeda G, Salaiza N, et al. Innate cytokines and costimulatory molecules expression in patients infected with Leishmania mexicana. Parasite Immunol 2007 29 : 117 126.
9. Bogdan C Rollinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today 1999 15 : 22 28.
10. Scott P. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991 147 : 149 155.
11. Silveira FT, Lainson R Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz 2004 99 : 239 251.
12. Peters N Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006 213 : 159 179.
13. Kedzierski L, Zhu Y Handman E. Leishmania vaccines: progress and problems. Parasitology 2006 133 : S87 S112.
14. + T cells. Curr Opin Immunol 2003 15 : 336 342.
15. Jiang H Chess L. An integrated view of suppressor T cell subsets in immunoregulation. Clin Invest 2004 114 : 1198 1208.
16. Trapani J Smyth M. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002 2 : 735 747.
17. Orange J Ballas Z. Natural killer cells in human health and disease. Clin Immunol 2006 118 : 1 10.
18. + T cell memory. Science 2002 297 : 2060 2063.
19. Schoenberger S, Toes R, van der Voort E, Offringa R Melief C. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998 393 : 480 483.
20. Melief C. Regulation of T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur J Immunol 2003 33 : 2645 2654.
21. + T cell responses against self- or non-self-antigens. Ann NY Acad Sci 2003 987 : 99 106.
22. + T cell effectors mechanisms in resistance to infection. Annu Rev Immunol 2000 18 : 275 308.
23. Lopez J, Lebowitz J, Beverly S, Rammensee H Overath P. Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages. Eur J Immunol 1993 23 : 217 223.
24. + T cells by Leishmania major infected dendritic cells. Infect Immun 2005 73 : 6620 6628.
25. + T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol 2006 177 : 3525 3533.
26. Kima P, Ruddle N McMahon-Pratt D. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8 T cells. J Immunol 1997 159 : 1828 1834.
27. Schaible U, Winau F, Sieling P, et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003 9 : 1039 1046.
28. Fonteneau J, Kavanagh D, Lirvall M, et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 2003 102 : 4448 4455.
29. Guermonprez P Amigorena S. Pathways for antigen cross presentation. Springer Semin Immunopathol 2005 26 : 257 271.
30. Winau F, Kaufmann S Schaible U. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell Microbiol 2004 6 : 599 607.
31. Kovacsovics-Bankowski M Rock K. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995 267 : 243 246.
32. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999 1 : 362 368.
33. Houde M, Bertholet S, Gagnon E, et al. Phagosomes are competent organelles for antigen cross-presentation. Nat 2003 425 : 402 406.
34. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, van Endert P Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003 425 : 397 402.
35. Huber M, Timms E, Mak E, Rollinghoff M Lohoff M. Effective and long lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun 1998 66 : 3968 3970.
36. Titus R. Involvement of specific Liyt-2+ T cells in the immunological control of experimental induced murine cutaneous leishmaniosis. Eur J Immunol 1987 17 : 1429 1433.
37. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 2002 168 : 3992 4000.
38. + T cells. J Exp Med 2004 199 : 1559 1566.
39. + T cells. Int Immunol 1991 3 : 587 597.
40. + T cells. Parasite Immunol 2003 25 : 559 567.
41. Conceição F, Perlaza B, Louis J Romero P. Leishmania major infection in mice primes for specific major histocompatibility complex class-I restricted cytotoxic T cell responses. Eur J Immunol 1994 24 : 2813 2817.
42. Farajnia S, Mahboudi F, Ajdari S, Reiner NE, Kariminia A Alimohammadian MH. Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response. Clin Exp Immunol 2005 139 : 498 505.
43. + T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 1994 62 : 2614 2618.
44. Da-Cruz A, Bittar R, Mattos M, et al. T cell mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long term evaluation alter therapy. Clin Diag Laboratory Immunol 2002 9 : 251 256.
45. Da-Cruz A, Bertho AL, Oliveira-Neto M Coutinho S. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 2005 153 : 537 543.
46. Gaafar A, Veress B, Permin H, Kharazmi A, Theander A Hassan A. Characterization of the local and systemic immune response in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol 1999 91 : 314 320.
47. Salaiza N, Volkow P, Pérez R, et al. Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Trop Med Int Health 1999 4 : 801 811.
48. Barral-Netto M, Barral A, Brodskyn C, Carvalho E Reed S. Cytotoxicity in human mucosal and cutaneous leishmaniosis. Parasite Immunol 1995 17 : 21 28.
49. Brodskyn C, Barral A, Boaventura V, Carvalho E Barral-Netto M. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 1997 159 : 4467 4473.
50. + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005 174 : 7147 7153.
51. + regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun 2005 73 : 5908 5914.
52. Roger K Titus R. The human cytokine response to Leishmania major early after exposure to the parasite in vitro. J Parasitol 2004 90 : 557 563.
53. Roger K Titus R. Characterization of the early cellular immune response to Leishmania major using peripheral blood mononuclear cells from Leishmania-naïve humans. Am J Trop Med Hyg 2004 71 : 568 576.
54. Conceição F, Hahne M, Schroter M, Louis J Tschopp J. The resolution of lesions induced by Leishmania major requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol 1998 28 : 237 245.
55. Eisert V, Münster U, Simon M Moll H. The course of Leishmania major infection in mice lacking granzyme-mediated mechanisms. Immunobiol 2002 205 : 314 320.
56. Moll H, Müller C, Gillitzer R, et al. Expression of T-cell-associated serine proteinase 1 during murine Leishmania major infection correlates with susceptibility to disease. Infect Immun 1991 59 : 4701 4708.
57. + T cells from susceptible mice. Immunobiol 1994 82 : 255 261.
58. Alexander C, Kaye P Engwerda C. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 2001 31 : 1199 1210.
59. Huang FP, Xu D, Esfandiari EO, Sands W, Wei XQ Liew FY. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol 1998 160 : 4143 4147.
60. + cytotoxic effectors. Exp Parasitol 1999 93 : 161 170.
61. Bousoffara T, Louzir H, Salah B Dellagi K. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. J Infect Dis 2004 189 : 1265 1273.
62. Eidsmo L, Nylen S, Khamesipour A, Hedblad M, Chiodi F Akuffo H. The contribution of the Fas/Fasl apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous leishmaniasis. Am J Path 2005 166 : 1099 1108.
63. Moore KJ Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994 152 : 2930 2937.
64. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand J Infect Dis 2001 33 : 483 487.
65. Kumar J, Okada S, Clayberger C Krensky AM. Granulysin: a novel antimicrobial. Expert Opin Invest Drugs 2001 10 : 321 329.
66. + cytotoxic T cells and Leishmania-infected macrophages. J Exp Med 1991 174 : 499 505.